Improved Stability for Enhanced Efficacy
Amoxycillin 500 mg + Potassium Clavulanate 125 mg + Lactic Acid Bacillus 60 Million Spore Tablets
OPA Technology
O₂ barrier with OPA technology
Protects highly hygroscopic clavulanic acid from degradation
Protects highly hygroscopic clavulanic acid from degradation
Key Benefits
High therapeutic response
Complete eradication of β-lactamase producing pathogens
Complete eradication of β-lactamase producing pathogens
Obtained from world’s best sources
More active than co-trimoxazole against providencia stuartii, proteus vulgaris and klebsiella species.
Indications
- RTI (Sinusitis, Bronchitis, Pneumonia)
- Post surgical infections
- UTI (Recurrent cystitis)
- Diabetic foot infections
- Orodental infection
